Clear Search sequence regions


  • 13 hode (3)
  • acid (17)
  • control group (1)
  • dha (1)
  • eicosanoids (2)
  • esters (1)
  • free (3)
  • humans (1)
  • lipoxins (4)
  • patients (1)
  • plasma (1)
  • prostaglandins (3)
  • resolvin d1 (1)
  • signal (1)
  • stroke (7)
  • Sizes of these terms reflect their relevance to your search.

    There is limited information available regarding the association of plasma free fatty acids (FFA) and inflammation mediators with ischemic stroke. At the same time, new treatment strategies are being pursued. The aim of this study was to carry out a thorough analysis of inflammation with multiple FFA-derivative mediators after and ischemic stroke and standard treatment. HPLC separations of 17 eicosanoids were performed using an Agilent Technologies 1,260 liquid chromatograph. The profiles of the esters of fatty acids were labelled by means of gas chromatography. FFA, and eicosanoid profiles in the group of patients after ischemic stroke significantly differed from the profile of the control group. Studies confirmed the involvement of derivative synthesis pathways responsible for the inflammation, especially palmitic acid (9 and 13 HODE), arachidonic acid, EPA and DHA. Arachidonic acid derivatives were synthesised on 5LOX, 15 LOX and COX pathways with the participation of prostaglandins while omega 3 derivatives strengthened the synthesis of resolvins, RevD1 in particular. The ability to accelerate the quenching of inflammation after ischemic stroke seems to be a promising strategy of stroke treatment in its early stage. In this context, our study points to lipoxins, RevD1, and 9, 13 HODE as the most important derivatives.

    Citation

    Małgorzata Szczuko, Dariusz Kotlęga, Joanna Palma, Agnieszka Zembroń-Łacny, Anna Tylutka, Monika Gołąb-Janowska, Arleta Drozd. Lipoxins, RevD1 and 9, 13 HODE as the most important derivatives after an early incident of ischemic stroke. Scientific reports. 2020 Jul 30;10(1):12849

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32732956

    View Full Text